Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Chesapeake Energy Corporation (CHK), Talisman Energy Inc. (USA) (TLM): Carl Icahn’s Latest Move in Energy and Other Top Oil Bets

Page 1 of 2

Carl Icahn’s Icahn Capital LP has disclosed a new move with the Securities and Exchange Commission involving Chesapeake Energy Corporation (NYSE:CHK), in which the famed investor has increased his activist position to 73.05 million shares, which amounts to 10.98% of the company’s common stock. That’s an increase of 6.60 million shares to his position held at the end of 2014, with the purchase of new additional shares taking place on March 11 at a price per share of $14.15. In addition to Chesapeake Energy, we’ll take a look at two of Icahn’s other top energy plays, CVR Energy, Inc. (NYSE:CVI) and Talisman Energy Inc. (USA) (NYSE:TLM). Icahn’s significant exposure to energy took a hit at the firm’s earnings last year. Icahn’s publicly-traded investment vehicle, Icahn Enterprises LP (NASDAQ:IEP) posted a loss of $225 million for 2014, versus a net profit of $1.0 billion a year earlier. It was the first time that the company posted a loss since the financial crisis of 2008.

Carl Icahn - Icahn Capital Lp

Icahn first disclosed an activist position in Chesapeake Energy Corporation (NYSE:CHK) late in 2010, with ownership of 38.63 million shares, which amounted to a 5.80% stake at the time. Shares peaked at more than $35 in early 2011, a more than 50% hike from when Icahn’s position was disclosed. However his attempts for board representation were rebuffed, as were his pleas to slow the company’s purchases and sell assets. Frustrated, he eventually sold his stake in the middle of 2011.

However in early 2012 he came back to the stock again and built another large activist position, and took another shot at reforming the company’s board. This time Icahn was successful at not only remaking the board, but in eventually ousting Founder and CEO Aubrey McClendon in early 2013. The stock enjoyed a strong run from that point until the middle of 2014, again gaining more than 50% during that timeframe. However, plummeting oil prices have wreaked havoc on the stock since, sending it plunging back down more than 50%, and prompting Icahn’s latest top up.

The most recent dip occurred on February 25 following disappointing earnings results in which the Oklahoma City-based oil and natural gas company actually topped revenue estimates with its $5.05 billion in revenue outdoing the $4.83 billion estimates, yet still fell short of earnings estimates with its earnings per share of $0.11 falling $0.13 short of estimates. Shares fell from just under $20 before the earnings release, to less than $14 two weeks later. Despite his large positions, Icahn was not the largest shareholder among funds we track, that distinction went to fellow billionaire Mason Hawkins, whose fund Southeastern Asset Management held 73.87 million shares at the end of 2014, up 18% during the fourth quarter.

Nor was Chesapeake Energy Corporation (NYSE:CHK) Icahn’s top energy pick heading into 2015; that honor belonged to CVR Energy, Inc. (NYSE:CVI), which was not only one of Icahn’s top overall picks, but also his top pick among stocks with a relatively small cap. That makes the stock quite significant given the success of our small-cap strategy, which is based on the top small-cap stock picks of world-class investors, and has returned 132.0% since we first launched our newsletter at the end of August 2012 (through March 11, 2015).

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!